Navigation Links
delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
Date:8/21/2009

SOUTH BURLINGTON, Vt., Aug. 4 /PRNewswire-FirstCall/ -- delSECUR CORPORATION, a Nevada Corporation, (Pink Sheets: DLSC) announced today that its Board of Directors has accepted, subject to the approval of the majority of the shareholders entitled to vote, an agreement to purchase the Intellectual Property Assets of delSECUR CORPORATION. The consideration for such purchase will be in the form of a 49% interest in the shares of common stock of Q Tech Systems, Inc., an Ontario, Canada Corporation.

The primary asset to be acquired by Q Tech is the del-ID technology, a patented device and system of authenticating individuals through biometric means invented by Pierre de Lanauze, the former President & CEO of delSECUR. Q Tech, which also develops and markets technologies to enhance security and identification processes, plans to incorporate the del-ID technology with its proprietary technology. "Q Tech will be immediately focusing on the invention of Pierre de Lanauze's analog technology and believes it can make this combined technology commercially viable and bring it to the marketplace," said Randall McCormick, delSECUR's current CEO.

Mr. McCormick further stated, "We believe this is a great opportunity for the advancement of the del-ID technology and puts our business plan and mission statement immediately into action without further delay.

It is time to bring the del-Id technology to the next level and to test its capabilities. With this new alliance we are much closer to that goal."

delSECUR, a public company (Pink Sheets: DLSC) with its head office in S. Burlington, VT., is a technology development company of a unique authentication process based on abstract images of biological data collected from the fingers of living persons.

For further information contact us at: investorrelations@delsecur.com

This Press Release may contain forward-looking statements. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and other similar statements. Statements that are not historical facts, including statements relating to anticipated future earnings, margins, and other operating results, future growth, construction plans and anticipated capacities, production schedules and entry into expanded markets are forward-looking statements. Such forward-looking statements, based upon the current beliefs and expectations of our management, are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements and are subject to the risks normally associated with the completions of a corporate transaction. The information set forth herein should be read in light of such risks. We assume no obligation to update the information contained in this press release, except as required under applicable law.


'/>"/>
SOURCE delSECUR CORPORATION
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
2. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
3. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
4. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
5. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
6. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
7. Carbon Disclosure Project: Worlds largest corporations seek clarity on climate change regulation
8. L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation
9. Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results
10. Corporations can profit from being environmentally friendly
11. Communication Intelligence Corporation Closes $3.6 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
(Date:6/22/2016)... 2016 Research and Markets has announced the ... to their offering. The ... $29.3 billion in 2013. The market is expected to grow at ... to 2020, increasing from $50.6 billion in 2015 to $96.6 billion ... the forecast period (2015 to 2020) are discussed. As well, new ...
(Date:6/22/2016)... ... June 21, 2016 , ... New light-based technologies that facilitate a “look inside” ... to enable both compact, wearable devices for point-of-care diagnostics as well as powerful new ... Recent work and visionary future directions are detailed in a new open-access article by ...
Breaking Biology Technology: